These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
225 related articles for article (PubMed ID: 7049373)
1. L-Asparaginase as a single agent in acute lymphocytic leukemia: survey of studies form Childrens Cancer Study Group. Nesbit ME; Ertel I; Hammond GD Cancer Treat Rep; 1981; 65 Suppl 4():101-7. PubMed ID: 7049373 [TBL] [Abstract][Full Text] [Related]
2. Effective dose of L-asparaginase for induction of remission in previously treated children with acute lymphocytic leukemia: a report from Childrens Cancer Study Group. Ertel IJ; Nesbit ME; Hammond D; Weiner J; Sather H Cancer Res; 1979 Oct; 39(10):3893-6. PubMed ID: 383278 [TBL] [Abstract][Full Text] [Related]
3. Evaluation of intramuscular versus intravenous administration of L-asparaginase in childhood leukemia. Nesbit M; Chard R; Evans A; Karon M; Hammond GD Am J Pediatr Hematol Oncol; 1979; 1(1):9-13. PubMed ID: 295576 [TBL] [Abstract][Full Text] [Related]
4. Sequential combination of methotrexate and L-asparaginase in the treatment of refractory acute leukemia. Amadori S; Tribalto M; Pacilli L; De Laurentis C; Papa G; Mandelli F Cancer Treat Rep; 1980; 64(8-9):939-42. PubMed ID: 6934851 [TBL] [Abstract][Full Text] [Related]
5. L-Asparaginase, vincristine, and prednisone for induction of first remission in acute lymphocytic leukemia. Ortega JA; Nesbit ME; Donaldson MH; Hittle RE; Weiner J; Karon M; Hammond D Cancer Res; 1977 Feb; 37(2):535-40. PubMed ID: 264412 [TBL] [Abstract][Full Text] [Related]
6. Asparaginase and methotrexate combination chemotherapy in relapsed acute lymphoblastic leukemia in adults. Yap BS; McCredie KB; Keating MJ; Bodey GP; Freireich EJ Cancer Treat Rep; 1981; 65 Suppl 1():83-7. PubMed ID: 6948610 [TBL] [Abstract][Full Text] [Related]
7. [Complete remission obtained in refractory acute lymphocytic leukemia using high-dose cytosine arabinoside combined with low-dose L-asparaginase]. Inagaki C; Ito K; Omori I; Shimazaki C; Nishio A; Haruyama H; Isemura T; Nakagawa M; Ijichi H Gan To Kagaku Ryoho; 1985 Feb; 12(2):379-82. PubMed ID: 3855616 [TBL] [Abstract][Full Text] [Related]
8. [L-asparaginase study results (phase II of the clinical trials)]. Kondrat'eva NA; Kruglova GV; Lorie IuI; Koshel' IV; Kurmashov VI Antibiotiki; 1980 Sep; 25(9):686-9. PubMed ID: 6998370 [TBL] [Abstract][Full Text] [Related]
9. Randomized comparison of moderate-dose methotrexate infusions to oral methotrexate in children with intermediate risk acute lymphoblastic leukemia: a Childrens Cancer Group study. Lange BJ; Blatt J; Sather HN; Meadows AT Med Pediatr Oncol; 1996 Jul; 27(1):15-20. PubMed ID: 8614385 [TBL] [Abstract][Full Text] [Related]
10. [L-asparaginase in combined treatment of acute leukemia not affecting the bone marrow]. Cyklis R; Armata J; Legutko L Acta Haematol Pol; 1974; 5(3):201-6. PubMed ID: 4528224 [No Abstract] [Full Text] [Related]
11. Asparaginase and amino acids in cancer therapeutics. Cancer and Leukemia Group B Investigators. Holland JF; Ohnuma T Cancer Treat Rep; 1981; 65 Suppl 4():123-30. PubMed ID: 7049376 [TBL] [Abstract][Full Text] [Related]
12. [Attempts at treatment of acute leukemia with L-asparaginase]. Lawkowicz W; KrzemiĆska-Lawkowiczowa ; Kozlowska J; Polubiec A; Derulska D; Kolakowska-Polubiec K; Litwin J; Rokicka R Acta Haematol Pol; 1971; 2(4):305-10. PubMed ID: 5293225 [No Abstract] [Full Text] [Related]
13. Asparaginase in combination chemotherapy for remission induction of childhood acute lymphocytic leukemia. Pratt CB; Roberts D; Shanks E; Warmath EL; Jackson R Cancer Res; 1973 Sep; 33(9):2020-5. PubMed ID: 4516498 [No Abstract] [Full Text] [Related]
14. L-asparaginase reinduction and maintenance therapy in previously treated acute lymphocytic leukemia. Sieger L; Higgins G; Ortega J; Shore N; Williams K Med Pediatr Oncol; 1976; 2(3):327-32. PubMed ID: 1068340 [TBL] [Abstract][Full Text] [Related]
15. [Recent advances in L-asparaginase studies]. Taguchi T Gan To Kagaku Ryoho; 1988 May; 15(5):1815-25. PubMed ID: 3285797 [TBL] [Abstract][Full Text] [Related]
16. [Treatment with L-asparaginase of renal and testicular involvement in acute lymphoblastic leukemia in children (author's transl)]. Armata J; Cyklis R; Legutko L Acta Paediatr Belg; 1974; 28(1):49-57. PubMed ID: 4526297 [No Abstract] [Full Text] [Related]
17. Favorable remission induction rate with twice weekly doses of L-asparaginase. Jaffe N; Traggis D; Das L; Frauenberger G; Hann HW; Kim BS; Bishop Y Cancer Res; 1973 Jan; 33(1):1-4. PubMed ID: 4565907 [No Abstract] [Full Text] [Related]
18. Comparison of idarubicin to daunomycin in a randomized multidrug treatment of childhood acute lymphoblastic leukemia at first bone marrow relapse: a report from the Children's Cancer Group. Feig SA; Ames MM; Sather HN; Steinherz L; Reid JM; Trigg M; Pendergrass TW; Warkentin P; Gerber M; Leonard M; Bleyer WA; Harris RE Med Pediatr Oncol; 1996 Dec; 27(6):505-14. PubMed ID: 8888809 [TBL] [Abstract][Full Text] [Related]
19. Antibody response to Escherichia coli L-asparaginase. Prognostic significance and clinical utility of antibody measurement. Cheung NK; Chau IY; Coccia PF Am J Pediatr Hematol Oncol; 1986; 8(2):99-104. PubMed ID: 3526939 [TBL] [Abstract][Full Text] [Related]
20. Greater decrease of fibrinogen as compared to antithrombin III in L-asparaginase treated leukemia patients. Vicarioto M; Rosolen A; Cappellato MG; Zanesco L; Girolami A Folia Haematol Int Mag Klin Morphol Blutforsch; 1986; 113(5):663-9. PubMed ID: 2435632 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]